Centre Hospitalier Universitaire de Bordeaux / CHU Bordeaux

Hospital


Location: Bordeaux, France (FR) FR

ISNI: 0000000405937118

ROR: https://ror.org/01hq89f96

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Isolated nocturnal and isolated daytime hypertension associate with altered cardiovascular morphology and function in children with chronic kidney disease: findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease study (2019) Düzova A, Karabay Bayazit A, Canpolat N, Niemirska A, Kaplan Bulut I, Azukaitis K, Karagoz T, et al. Journal article Delineation of the clinical phenotype caused by de novo CLTC variants (2019) Sa MJN, Venselaar H, Wiel L, Trimouille A, Lasseaux E, Naudion S, Lacombe D, et al. Conference contribution Therapeutic hypothermia for acute ischaemic stroke. Results of a European multicentre, randomised, phase III clinical trial (2019) Van Der Worp HB, Macleod MR, Bath PMW, Bathula R, Christensen H, Colam B, Cordonnier C, et al. Journal article Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study (2019) Combe C, Mann J, Goldsmith D, Dellanna F, Zaoui P, London G, Denhaerynck K, et al. Journal article An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients. (2019) Sommerer C, Suwelack B, Dragun D, Schenker P, Hauser IA, Witzke O, Hugo C, et al. Journal article De novo CLTC variants are associated with a variable phenotype from mild to severe intellectual disability, microcephaly, hypoplasia of the corpus callosum, and epilepsy (2019) Nabais Sá MJ, Venselaar H, Wiel L, Trimouille A, Lasseaux E, Naudion S, Lacombe D, et al. Journal article Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study (2019) Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, et al. Journal article Non-specific gastrointestinal features: Could it be Fabry disease? (2018) Hilz MJ, Arbustini E, Dagna L, Gasbarrini A, Goizet C, Lacombe D, Liguori R, et al. Journal article Proposal of a rating scale to recognize Fabry disease in patients with nonspecific gastrointestinal symptoms (2018) Hilz MJ, Arbustini E, Dagna L, Gasbarrini A, Goizet C, Lacombe D, Liguori R, et al. Conference contribution Do we understand the pathophysiology of gastrointestinal symptoms in patients with Fabry disease? (2018) Hilz MJ, Arbustini E, Dagna L, Gasbarrini A, Goizet C, Lacombe D, Liguori R, et al. Conference contribution
1 ... 3 4 5 6 7